Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:00 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.7% | 203,212 (+10.15%) | View |
| 2024-02-14 3:04 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 2,221,422 6.71% | 485,000 (+27.93%) | View |
| 2024-02-14 07:28 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 3,152,341 9.5% | 604,216 (+23.71%) | View |
| 2024-02-13 5:03 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX LLC | 894,826 2.7% | -1,367,374 (-60.44%) | View |
| 2024-02-09 10:06 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | MORGAN STANLEY MS | 1,943,705 5.9% | 1,943,705 (New Position) | View |
| 2024-02-02 12:40 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,911,399 5.77% | 512,416 (+36.63%) | View |
| 2024-02-02 06:05 am Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | TimesSquare Capital Management LLC | 0 0% | -1,429,310 (Position Closed) | View |
| 2024-01-26 11:49 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 2,515,124 7.6% | 1,188,593 (+89.60%) | View |
| 2024-01-22 5:05 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm Biocapital Advisors LP | 1,927,506 5.8% | 1,927,506 (New Position) | View |
| 2023-05-05 3:28 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,398,983 5.22% | 1,398,983 (New Position) | View |
| 2023-02-14 4:00 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,001,585 7.5% | -90,168 (-4.31%) | View |
| 2023-02-14 3:04 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,736,422 6.51% | 333,091 (+23.74%) | View |
| 2023-02-14 2:33 pm Unchanged | 13G | TARSUS PHARMACEUTICALS INC TARS | PERCEPTIVE ADVISORS LLC | 1,296,416 4.9% | 0 (Unchanged) | View |
| 2023-02-14 10:09 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,548,125 9.6% | 534,524 (+26.55%) | View |
| 2023-02-13 5:52 pm Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX LLC | 2,262,200 8.5% | -725,131 (-24.27%) | View |
| 2023-02-10 10:10 am Unchanged | 13G | TARSUS PHARMACEUTICALS INC TARS | Flynn James E | 1,324,214 4.96% | 0 (Unchanged) | View |
| 2023-02-09 11:01 am Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 1,326,531 4.9% | -14,728 (-1.10%) | View |
| 2023-02-08 1:16 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock Inc. BLK | 1,341,259 5% | 1,341,259 (New Position) | View |
| 2023-02-03 08:16 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | TimesSquare Capital Management LLC | 1,429,310 5.36% | 1,429,310 (New Position) | View |
| 2022-05-13 4:00 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,091,753 7.9% | 2,091,753 (New Position) | View |